Sanofi Consumer Healthcare India Ltd
The Board of Directors at its meeting held on Tuesday, 28th July 2026, considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this ....
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 28 Jul 2026, 08:04 PM IST · BSE ID: 9e7005e9-5f06-430c-b398-71dd587f2696
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its financial results showing a quarterly profit of ₹ 688 Million and revenue of ₹ 2,357 Million.
🤖 AI Summary
- Board approved unaudited financial results for Q1 FY27 and half year ended June 30, 2026.
- Profit for Q1 FY27 (June 30, 2026) was ₹ 688 Million.
- Revenue from Operations for Q1 FY27 (June 30, 2026) reached ₹ 2,357 Million.
- Half-year Profit for the period ended June 30, 2026, was ₹ 1,366 Million.
- Total Assets were ₹ 7,064 Million as of June 30, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q1 FY27)
₹ 2,357 Million
6.70%
Profit for the period (Q1 FY27)
₹ 688 Million
13.34%
Revenue from Operations (Half year ended 30.06.2026)
₹ 4,649 Million
18.15%
Profit for the period (Half year ended 30.06.2026)
₹ 1,366 Million
23.39%
Basic and diluted earnings per share (Q1 FY27)
₹ 29.87
13.39%
Total Assets (as at June 30, 2026)
₹ 7,064 Million
Cash and cash equivalents (as at June 30, 2026)
₹ 4,902 Million
🏢 How This Affects the Company
Revenue from Operations increased to ₹ 2,357 Million in Q1 FY27 from ₹ 2,209 Million in Q1 FY26, indicating continued sales performance.
Profit for the period rose to ₹ 688 Million in Q1 FY27 compared to ₹ 607 Million in Q1 FY26. Cash and cash equivalents increased to ₹ 4,902 Million as of June 30, 2026, from ₹ 3,748 Million as of December 31, 2025.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as the company's financial performance, including a Q1 FY27 profit of ₹ 688 Million and half-year profit of ₹ 1,366 Million, impacts the overall value of their holdings.
🔍
Management Signal
The approval and disclosure of unaudited financial results indicate management's adherence to regulatory requirements and transparency regarding financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor Revenue from Operations and Profit for the period.
Update on Other Financial Liabilities — track changes from ₹ 1,772 Million.
Management commentary — assess outlook on operating expenses and current liabilities.
LOW RISK
Unaudited financial results show growth in key metrics, with no immediate red flags.
💡 Investor Takeaway
Sanofi Consumer Healthcare India reported a Profit for the period of ₹ 688 Million for Q1 FY27, up from ₹ 607 Million in Q1 FY26. Revenue from Operations increased to ₹ 2,357 Million, compared to ₹ 2,209 Million in the prior year's quarter. Half-year profit for H1 FY27 reached ₹ 1,366 Million.
⚖️ Strengths & Concerns
✅ Positives
- Profit for the period increased to ₹ 688 Million in Q1 FY27 from ₹ 607 Million in Q1 FY26, demonstrating improved profitability.
- Revenue from Operations rose to ₹ 2,357 Million in Q1 FY27 from ₹ 2,209 Million in Q1 FY26, reflecting sales growth.
⚠️ Concerns
- Current liabilities significantly increased to ₹ 3,271 Million as of June 30, 2026, from ₹ 1,284 Million as of December 31, 2025.
- Cost of Materials Consumed increased to ₹ 475 Million in Q1 FY27 from ₹ 402 Million in Q4 FY26.
📅 Company Track Record
In Q4 FY26 (quarter ended March 31, 2026), Sanofi Consumer Healthcare India reported a profit of ₹ 678 Million, with full-year FY26 profit at ₹ 2,401 Million. Domestic sales in Q4 FY26 recovered by 15.5% following product relaunches, indicating a trend of improving performance.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Sanofi Consumer Healthcare India's net profit in Q1 FY27?
Sanofi Consumer Healthcare India's Profit for the period in Q1 FY27 (quarter ended June 30, 2026) was ₹ 688 Million, up from ₹ 607 Million in Q1 FY26.
What was Sanofi Consumer Healthcare India's revenue from operations in Q1 FY27?
Revenue from Operations for Sanofi Consumer Healthcare India in Q1 FY27 (quarter ended June 30, 2026) was ₹ 2,357 Million, compared to ₹ 2,209 Million in the prior year's quarter.
What was the half-year profit for Sanofi Consumer Healthcare India for the period ended June 30, 2026?
The Profit for the period for the half-year ended June 30, 2026, for Sanofi Consumer Healthcare India was ₹ 1,366 Million.
What were Sanofi Consumer Healthcare India's total assets as of June 30, 2026?
Total assets for Sanofi Consumer Healthcare India stood at ₹ 7,064 Million as of June 30, 2026.
How did Sanofi Consumer Healthcare India's earnings per share change in Q1 FY27?
Basic and diluted earnings per share for Sanofi Consumer Healthcare India were ₹ 29.87 in Q1 FY27 (quarter ended June 30, 2026), compared to ₹ 26.36 in Q1 FY26.
Questions based on this BSE filing only. For information purposes.